Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of
Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China - PMC Back …

Objective To investigate the correlation of M-type phospholipase A2 receptor (PLA2R)
expression and serum anti-PLA2R antibody with the clinical parameters and prognosis of …

Background: Idiopathic Membranous Nephropathy (iMN) is the most common cause of
nephrotic syndrome in adults. Approximately one third of patients with iMN progress to end …

Background The M-type phospholipase A2 receptor (PLA2R) is a specific target autoantigen
identified in idiopathic membranous nephropathy (IMN). The autoantibody against PLA2R …

Objective To explore the value of anti-phospholipase A2 receptor (PLA2R) antibody in the
diagnosis and disease activity monitoring of idiopathic membranous nephropathy (IMN) …

Objective To investigate the correlation of serum anti-M-type phospholipase A2 receptor
(PLA2R) antibody with laboratory parameters of idiopathic membranous nephropathy (IMN) …

Objectives: This study was to investigate the effects of anti-M-type phospholipase A2
receptor (PLA2R) antibody in diagnosing and monitoring the progresssion in idiopathic …

M-type phospholipase A2 receptor (PLA2R) is the major target antigen in primary
membranous nephropathy (PMN). Previous studies have evaluated the diagnostic value of …

Background. M‐type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible
for idiopathic membranous nephropathy (IMN). However, serum PLA2R antibody (PLA2R …

Objective To examine the expression of phospholipase A2 receptor (PLA2R) in renal tissues
and the level of anti-PLA2R antibody in serum in patients with idiopathic membranous …